These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

577 related items for PubMed ID: 8160093

  • 1. Incidence of second solid cancer in patients after treatment of Hodgkin's disease.
    Glanzmann C, Veraguth A, Lütolf UM.
    Strahlenther Onkol; 1994 Mar; 170(3):140-6. PubMed ID: 8160093
    [Abstract] [Full Text] [Related]

  • 2. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C.
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [Abstract] [Full Text] [Related]

  • 3. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S, Marcheselli L, Bari A, Marcheselli R, Pozzi S, Luminari S, Lombardo M, Buda G, Lazzaro A, Gobbi PG, Stelitano C, Morabito F, Quarta G, Brugiatelli M.
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [Abstract] [Full Text] [Related]

  • 4. Breast cancer and other second neoplasms after childhood Hodgkin's disease.
    Bhatia S, Robison LL, Oberlin O, Greenberg M, Bunin G, Fossati-Bellani F, Meadows AT.
    N Engl J Med; 1996 Mar 21; 334(12):745-51. PubMed ID: 8592547
    [Abstract] [Full Text] [Related]

  • 5. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
    De Bruin ML, Sparidans J, van't Veer MB, Noordijk EM, Louwman MW, Zijlstra JM, van den Berg H, Russell NS, Broeks A, Baaijens MH, Aleman BM, van Leeuwen FE.
    J Clin Oncol; 2009 Sep 10; 27(26):4239-46. PubMed ID: 19667275
    [Abstract] [Full Text] [Related]

  • 6. Analysis of the risk of solid tumor following Hodgkin's disease.
    Maurizi Enrici R, Anselmo AP, Osti MF, Santoro M, Tombolini V, Mandelli F, Biagini C.
    Haematologica; 1997 Sep 10; 82(1):57-63. PubMed ID: 9107084
    [Abstract] [Full Text] [Related]

  • 7. Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease.
    Henry-Amar M.
    J Natl Cancer Inst; 1983 Nov 10; 71(5):911-6. PubMed ID: 6580491
    [Abstract] [Full Text] [Related]

  • 8. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
    Mauch PM, Kalish LA, Marcus KC, Shulman LN, Krill E, Tarbell NJ, Silver B, Weinstein H, Come S, Canellos GP, Coleman CN.
    Cancer J Sci Am; 1995 Nov 10; 1(1):33-42. PubMed ID: 9166452
    [Abstract] [Full Text] [Related]

  • 9. Risk of second cancers after treatment for Hodgkin's disease.
    Tucker MA, Coleman CN, Cox RS, Varghese A, Rosenberg SA.
    N Engl J Med; 1988 Jan 14; 318(2):76-81. PubMed ID: 3336397
    [Abstract] [Full Text] [Related]

  • 10. Quantitative risk of second cancer in patients in first complete remission from early stages of Hodgkin's disease.
    Henry-Amar M.
    NCI Monogr; 1988 Jan 14; (6):65-72. PubMed ID: 3352791
    [Abstract] [Full Text] [Related]

  • 11. Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followup.
    Coltman CA, Dixon DO.
    Cancer Treat Rep; 1982 Apr 14; 66(4):1023-33. PubMed ID: 7074630
    [Abstract] [Full Text] [Related]

  • 12. [Radiotherapy in adults with localized supradiaphragmatic stages CS I/II of Hodgkin's disease. 2. The special aspects of radiotherapy: dosage, fractionation, focal volumes, risks, conclusions].
    Glanzmann C, Lütolf UM.
    Strahlenther Onkol; 1993 Oct 14; 169(10):570-83. PubMed ID: 8235981
    [Abstract] [Full Text] [Related]

  • 13. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
    Liauw SL, Sylvester JE, Morris CG, Blasko JC, Grimm PD.
    Int J Radiat Oncol Biol Phys; 2006 Nov 01; 66(3):669-73. PubMed ID: 16887293
    [Abstract] [Full Text] [Related]

  • 14. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
    Koontz BF, Kirkpatrick JP, Clough RW, Prosnitz RG, Gockerman JP, Moore JO, Prosnitz LR.
    J Clin Oncol; 2006 Feb 01; 24(4):605-11. PubMed ID: 16446333
    [Abstract] [Full Text] [Related]

  • 15. Second malignant tumours in childhood Hodgkin's disease.
    Jenkin D, Greenberg M, Fitzgerald A.
    Med Pediatr Oncol; 1996 Jun 01; 26(6):373-9. PubMed ID: 8614372
    [Abstract] [Full Text] [Related]

  • 16. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
    Glanzmann C, Lütolf UM.
    Strahlenther Onkol; 1993 Aug 01; 169(8):449-58. PubMed ID: 8356505
    [Abstract] [Full Text] [Related]

  • 17. Risk of subsequent solid tumors after non-Hodgkin's lymphoma: effect of diagnostic age and time since diagnosis.
    Hemminki K, Lenner P, Sundquist J, Bermejo JL.
    J Clin Oncol; 2008 Apr 10; 26(11):1850-7. PubMed ID: 18347006
    [Abstract] [Full Text] [Related]

  • 18. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Brusamolino E, Baio A, Orlandi E, Arcaini L, Passamonti F, Griva V, Casagrande W, Pascutto C, Franchini P, Lazzarino M.
    Clin Cancer Res; 2006 Nov 01; 12(21):6487-93. PubMed ID: 17085663
    [Abstract] [Full Text] [Related]

  • 19. Malignant breast tumors after radiotherapy for a first cancer during childhood.
    Guibout C, Adjadj E, Rubino C, Shamsaldin A, Grimaud E, Hawkins M, Mathieu MC, Oberlin O, Zucker JM, Panis X, Lagrange JL, Daly-Schveitzer N, Chavaudra J, de Vathaire F.
    J Clin Oncol; 2005 Jan 01; 23(1):197-204. PubMed ID: 15625374
    [Abstract] [Full Text] [Related]

  • 20. High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation.
    Forrest DL, Hogge DE, Nevill TJ, Nantel SH, Barnett MJ, Shepherd JD, Sutherland HJ, Toze CL, Smith CA, Lavoie JC, Song KW, Voss NJ, Gascoyne RD, Connors JM.
    J Clin Oncol; 2005 Nov 01; 23(31):7994-8002. PubMed ID: 16204014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.